Torrent Pharmaceuticals has informed that: a meeting of the Board of Directors will be held on Tuesday, 30-May-23, to consider and approve the Audited Financial Results of the Company for the year ended on 31-Mar-23. In the above meeting, the Board would also consider the following: Recommendation of final dividend, if any, on the equity shares of the Company, for the year 2022-23, taking enabling resolutions for raising of funds by issue of Equity Shares including Convertible Bonds / Debentures through Qualified Institutional Placement (QIP) and / or Depository Receipts or any other modes. If approved by the Board of Directors, the said item will be placed for Shareholders' approval in the ensuing Annual General Meeting.
The above information is a part of company’s filings submitted to BSE.
